Fig. 1From: Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence studyFlow diagram and timeline of the study. A Flow diagram for the selection of the patients in the study. B Timeline of treatment and data collection during the study. The numbers represent months since the baseline visit (0 month). -3 months refers to the observation period lasting 3 months before baselineBack to article page